Month: December 2017

Roche Holding AG’s RHHBY member, Genentech announced that the FDA has converted accelerated approval for Avastin (received in May 2009) for previously treated glioblastoma, most aggressive form of brain cancer, to full approval. The full approval was based on data from the phase III EORTC 26101study in which Avastin-based treatment increased the time to disease progression or death compared to chemotherapy alone. The study, however, did not meet the primary endpoint as there was no significant increase in overall survival with Avastin-based treatment. […]

Clovis Oncology CLVS announced the FDA has granted priority review to its supplemental new drug application (sNDA) looking for label expansion of its marketed drug, Rubraca (rucaparib). The sNDA is looking to expand Rubraca’s label as a maintenance treatment for patients with platinum-sensitive recurrent ovarian cancer regardless of a patient’s BRCA mutation status. […]

A successful investor understands the importance of retaining well-performing stocks in the portfolio at the right time. Indicators of a stock’s bullish run include a rise in share price and strong fundamentals. Nutanix Inc. […]

Revance Therapeutics, Inc. RVNC shares surged more than 33% on Dec 5 after the company announced positive top-line results from two pivotal phase III studies, evaluating its next-generation neuromodulator, RT002 (daxibotulinumtoxin), for reducing wrinkles that lies between the brows (glabellar lines). Both the phase III studies, SAKURA 1 and SAKURA 2, met their primary and secondary endpoints, demonstrating highly statistically significant improvement in severity of glabellar lines with RT002 against placebo […]

On Dec 5, we issued an updated research report on Autoliv, Inc. ALV . Autoliv is a global leader in automotive safety systems […]

The healthcare sector has been under the spotlight for quite some time for a host of reasons —regulatory uncertainty, increasing consumerism and consolidation being the most prominent. The recent deal of merger between two of the industry stalwarts Aetna Inc. […]

Last week the pilot fiasco at American Airlines Group AAL was the most eye-catching event in the airline space. A scheduling error allowed its pilots to take leave during the upcoming winter holiday period. The prospect of an acute pilot shortage during the busy travel period caused panic among passengers […]

Goldman Sachs Group GS and Standard Chartered PLC SCBFF are looking to expand their operations in Poland by hiring new employees. While Goldman Sachs is planning to hire 250 employees in 2018, Standard Chartered targets to employ about 500 new workers. […]

Energy infrastructure provider Kinder Morgan, Inc. KMI recently announced its forecast for 2018. The company expects distributable cash flow (DCF) of $4.57 billion for the year […]

Things can change very quickly in the oil market. Just a few months ago, or until September, the commodity had a very difficult year when the broader market was hitting all-time highs. In June, U.S. […]

H&R Block Inc. HRB reported second-quarter fiscal 2018 (ended Oct 31, 2017) loss from continuing operations of 71 cents per share, narrower than the Zacks Consensus Estimate of loss of 73 cents. Better-than-expected results were attributable to a rise in revenues during the quarter […]

Williams Partners L.P. WPZ recently announced that the Virginia Southside II expansion project has initiated operations. Virginia Southside II is the fifth of the five major expansion projects of the Transco pipeline system in 2017. […]

Shares of Aegion Corporation AEGN have been performing well of late. The global leader in infrastructure protection and maintenance has witnessed its shares surge around 27.2% in the past three months. The company has also outperformed its industry' s growth of 11.9% […]

Pinnacle Foods Inc PF has been steadily expanding its portfolio through acquisitions and innovations. Also, the company has been gaining from its operational efficiency initiatives that have been boosting savings. However, underlying weaknesses in the Specialty segment and changing consumer preferences have been denting the company’s top line. […]

Shares of Wells Fargo & Company WFC rose 2% yesterday driven by the optimistic comments of CEO Tim Sloan on loan scenario in the fourth quarter based on improved customer activity. Despite several legal tensions, Wells Fargo remains focused on maintaining its financial position. […]

During the course of their financial planning and execution, while value investors miss the chance of betting on stocks that have bright long-term prospects, growth investors often end up investing in expensive stocks. Consequently, the quest for a mixed investment strategy led to the introduction of the GARP (growth at a reasonable price) approach. What GARPers look for is whether the stocks are somewhat undervalued and have solid sustainable growth potential ( Investopedia ) […]